South Florida’s 1st News With Andrew Colton

South Florida’s 1st News With Andrew Colton

You likely saw Andrew Colton reporting live from many of the major events that have shaped our world, including the Pentagon on 9/11, the crash of...Full Bio

 

The FDA Approves Another Injectable Weight Loss Drug

Senior Hispanic woman on medical scale

Photo: Terry Vine / DigitalVision / Getty Images

The FDA is approving another injectable weight loss drug from Eli Lilly.

The drug Mounjaro is approved to treat diabetes and now a variation approved for weight loss will be called Zepbound.

The FDA approved the drug for those with a BMI over 30 characterized as overweight with at least one health condition related to their weight.

Zepbound, generically called tirzepatide, helps suppress appetite to reduce food intake, and is injected once weekly, according to the FDA.

In clinical trials tirzepatide helped people lose an average of 52 pounds for subjects with a median weight of 231 pounds, in 72 weeks.

Zepbound is expected to be available in six dosage strengths by the end of December.

appetite to reduce food intake, and is injected once weekly, according to the FDA.


Sponsored Content

Sponsored Content